2025 annual financial data
ABVC BioPharma 2025 Operating margin
ABVC BioPharma 2025 operating margin with verified reported values.
Direct answer
Operating margin was -898.46%.
Operating income was -7,151,259 USD and net income was -7,908,554 USD.
Operating cash flow was -2,986,299 USD.
Get free ABVC BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 795,950 USD
- Operating income
- -7,151,259 USD
- Net income
- -7,908,554 USD
- Operating cash flow
- -2,986,299 USD